Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objective: To determine whether pulmonary arterial hypertension (PAH) is a prognostic factor for mortality in diffuse cutaneous systemic sclerosis (dcSSc), independent of interstitial lung disease (ILD). Methods: ILD was diagnosed by high‐resolution computed tomography and PAH (pulmonary arterial systolic pressure [PASP] ≥45 mm Hg) by echocardiography. All patients with ILD underwent testing for total lung capacity (TLC), forced vital capacity (FVC), and diffusing capacity for carbon monoxide. Results: Eighty‐six patients with dcSSc (mean age at diagnosis 44.5 years) were followed up for a median of 72.5 months. ILD was found in 52 patients (60%) and PAH in 18 (21%). ILD was associated with PAH in 15 patients. Seventeen patients died (19.8%), 9 of whom had PAH (P = 0.001) and 10 of whom had ILD (P = 0.99). By multivariate analysis, age at SSc diagnosis and PAH were the only independent predictors of death (hazard ratio [HR] 1.057, 95% confidence interval [95% CI] 1.009–1.109, P = 0.020 and HR 4.09, 95% CI 1.47–11.5, P = 0.007, respectively). Mean TLC and mean FVC were similar in ILD patients with and those without PAH (P = 0.71 and P = 0.40, respectively). Among ILD patients, age at SSc diagnosis and PAH were again the sole predictors of death (HR 1.073, 95% CI 1.003–1.149, P = 0.042 and HR 5.07, 95% CI 1.09–23.8, P = 0.038, respectively). Twenty ILD patients received at least 6 monthly pulses of intravenous cyclophosphamide (CYC). In CYC‐treated patients with PAH (n = 8), PASP increased significantly during the CYC regimen (mean ± SD 55 ± 14.5 mm Hg; P = 0.015 versus baseline), while TLC remained stable during the same period. Conclusion: These results indicate that, independent of ILD, PAH is a major prognostic factor for survival in dcSSc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
Battle, R. W., Davitt, M. A., Cooper, S. M., Buckley, L. M., Leib, E. S., Beglin, P. A., & Tischler, M. D. (1996) · Chest · doi:10.1378/chest.110.6.1515 · Cited by 158
Cited by
Tyndall, A. J., Bannert, B., Vonk, M., Airò, P., Cozzi, F., Carreira, P. E., Bancel, D. F., Allanore, Y., Müller-Ladner, U., Distler, O., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.114264 · Cited by 1,443
Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL
Chung, L., Liu, J., Parsons, L., Hassoun, P. M., McGoon, M., Badesch, D. B., Miller, D. P., Nicolls, M. R., & Zamanian, R. T. (2010) · Chest · doi:10.1378/chest.10-0260 · Cited by 431
Management of interstitial lung disease associated with connective tissue disease
Mathai, S. C., & Danoff, S. K. (2016) · BMJ · doi:10.1136/bmj.h6819 · Cited by 328
Solomon, J. J., Olson, A. L., Fischer, A., Bull, T., Brown, K. K., & Raghu, G. (2013) · European Respiratory Review · doi:10.1183/09059180.00005512 · Cited by 294
Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis
Nathan, S. D., Shlobin, O. A., Ahmad, S., Urbanek, S., & Barnett, S. D. (2007) · Chest · doi:10.1378/chest.06-2485 · Cited by 270
Metadata
- Authors
- Trad, S., Amoura, Z., Beigelman, C., Haroche, J., Costedoat, N., Boutin, L. T. H. D., Cacoub, P., Frances, C., Wechsler, B., Grenier, P., & Piette, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-12-29
- Volume
- 54
- Issue
- 1
- Pages
- 184-191
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2004452898
- Cited by
- 151
- References
- 1
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. https://app.cochat.ai/papers/10.1002/art.21538
- The paper
- Trad, S., Amoura, Z., Beigelman, C., Haroche, J., Costedoat, N., Boutin, L. T. H. D., Cacoub, P., Frances, C., Wechsler, B., Grenier, P., & Piette, J. (2006). Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis & Rheumatism. https://doi.org/10.1002/art.21538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.